MedTrace Logo

Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy

NCT04856436 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3094227

Last updated 2022-03-07

No results posted yet for this study

Summary

This is a nationwide cohort study to assess maternal and neonatal outcomes following exposure to benzodiazepines during pregnancy.

Conditions

  • Pregnancy Related
  • Benzodiazepines Causing Adverse Effects in Therapeutic Use
  • Congenital Anomaly

Interventions

DRUG

Benzodiazepine

Exposure to benzodiazepine during early pregnancy

Sponsors & Collaborators

Principal Investigators

  • Ju-Young Shin, PhD · Sungkyunkwan University

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-06-30
Completion
2021-07-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04856436 on ClinicalTrials.gov